Ratings
0
Nobody has rated this yet. Be the first!
Works
4
Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors
Differentiated thyroid carcinoma: a polygenic disease.
The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer
